4008-986-980
CN| EN

首页  > 平台实力  > 发表文章  > 基因组学

Inhibition of hepatitis B virus by the CRISPR/Cas9 system via targeting the conserved regions of the viral genome

2016-08-17

Liu X, Hao R D, Chen S L, et al.


摘要:


Hepatitis B virus (HBV) remains a global health threat as chronic HBV infection may lead to liver cirrhosis or cancer. Current antiviral therapies with nucleoside analogues can inhibit the replication of HBV, but do not disrupt the already existing HBV covalently closed circular DNA. The newly developed CRISPR (clustered regularly interspaced short palindromic repeats)/Cas9 (CRISPR-associated 9) system is a powerful tool to target cellular genome DNA for gene editing. In order to investigate the possibility of using the CRISPR/Cas9 system to disrupt the HBV DNA templates, we designed eight guide RNAs (gRNAs) that targeted the conserved regions of different HBV genotypes, which could significantly inhibit HBV replication both in vitro and in vivo. Moreover, the HBV-specific gRNA/Cas9 system could inhibit the replication of HBV of different genotypes in cells, and the viral DNA was significantly reduced by a single gRNA/Cas9 system and cleared by a combination of different gRNA/Cas9 systems.


文章链接:


http://jgv.microbiologyresearch.org/content/journal/jgv/10.1099/vir.0.000159



相关报道请点击:


安诺基因助力CRISPR/Cas9乙肝新疗法


  • 关注我们
  • 安诺基因
  • 医学健康

  • www.annoroad.com

网站地图 隐私说明 使用条款 联系我们

Copyright2012 genome.cn 安诺优达 版权所有

All rights reserved Annoroad JICP备12029022号-4

Inhibition of hepatitis B virus by the CRISPR/Cas9 system via targeting the conserved regions of the viral genome-基因组-平台实力-安诺优达
展开